Hostname: page-component-586b7cd67f-t8hqh Total loading time: 0 Render date: 2024-12-01T00:25:16.323Z Has data issue: false hasContentIssue false

Mucous membrane pemphigoid: nasal and laryngeal manifestations

Published online by Cambridge University Press:  31 May 2006

O. J. H. Whiteside
Affiliation:
Departments of Otolaryngology, Radcliffe Infirmary, Oxford, UK.
P. Martinez Devesa
Affiliation:
Departments of Otolaryngology, Wycombe Hospital, High Wycombe, UK.
I. Ali
Affiliation:
Department of Dermatology, Oxford Churchill Hospital, Oxford, UK.
J. W. R. Capper
Affiliation:
Departments of Otolaryngology, Wycombe Hospital, High Wycombe, UK.

Abstract

Mucous membrane pemphigoid (MMP) is a sub-epithelial blistering disease that primarily involves mucosal surfaces but may also involve the skin. Clinically, it appears as vesiculobullous lesions of the oral cavity and eyes, but other tissues such as the nasopharyngeal and laryngeal mucosa can also be affected. Ultimately, scarring and airway stenosis may occur. The condition should be managed by a multidisciplinary team led by a dermatologist. Immunosuppressive therapy forms the mainstay of treatment, with surgery having both a diagnostic role and a use in the treatment of complications such as airway obstruction. There must be a low threshold of suspicion for laryngeal involvement in this group of patients, so that prompt action can be taken. Once laryngeal stenosis has occurred repeated endoscopic laser excision of scar tissue can be used to maintain an adequate airway. Adjuvant use of mitomycin-C can be used beneficially in the treatment of laryngeal complications of MMP.

Type
Research Article
Copyright
© Royal Society of Medicine Press Limited 2003

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)